Produção Nacional
Use of recombinant luteinizing hormone for controlled ovarian hyperstimulation in infertile patients
2016; Brazilian Society of Assisted Reproduction; Volume: 20; Issue: 2 Linguagem: Inglês
10.5935/1518-0557.20160018
ISSN1518-0557
AutoresMônica Canêdo Silva Maia, Mário Silva Approbato, Tatiana M. da Silva, Eliamar A. B. Fleury, Eliane G. M. Sanchez, Reinaldo Satoru Azevedo Sasaki,
Tópico(s)Assisted Reproductive Technology and Twin Pregnancy
ResumoControlled ovarian stimulation has become an integral part of a high complexity infertility treatment.Treatment options with recombinant gonadotrophins add more to knowledge on folliculogenesis and ovarian steroidogenesis.Therefore, a literature search was conducted in the following data bases: Medline, Scielo and PubMed.The descriptors/key words used were ovarian stimulation, in vitro fertilization, recombinant luteinizing hormone, supplementation LH.The aim of this study was to review the available literature and to assess the benefits of using recombinant luteinizing hormone associated with recombinant follicle stimulating hormone in different populations who have undergone assisted reproduction procedures.
Referência(s)